Cargando…

Analysis of prognosis and treatment decisions for patients with second primary lung cancer following esophageal cancer

INTRODUCTION: As the long-term prognosis of esophageal cancer (EC) is improving, concerns of a second primary malignancy (SPM) have increased. However, research on lung cancer as the SPM after EC is limited. Therefore, we aimed to explore the prognostic factors and clinical treatment decisions of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jin-luan, Li, Hui, Wu, Qian, Zhou, Han, Li, Yi, Li, Yong-heng, Li, Jiancheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425047/ https://www.ncbi.nlm.nih.gov/pubmed/36052233 http://dx.doi.org/10.3389/fonc.2022.777934

Ejemplares similares

Surgical selection and regional lymph node dissection for stage I second primary lung cancer patients following surgery for stage I first primary lung cancer
por: Wu, Xiao, et al.
Publicado: (2023)

Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy
por: Qiu, Jianjian, et al.
Publicado: (2022)

Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study
por: Song, Congkuan, et al.
Publicado: (2020)

Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy
por: Shirai, Katsuyuki, et al.
Publicado: (2013)

Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women
por: Wang, Rong, et al.
Publicado: (2018)

Clinical Characteristics, Prognosis, and Nomogram for Esophageal Cancer Based on Adenosquamous Carcinoma: A SEER Database Analysis
por: Qian, Haisheng, et al.
Publicado: (2021)

Relationship between metastasis and second primary cancers in women with breast cancer
por: Li, Chaofan, et al.
Publicado: (2022)

Incorporation of PET Metabolic Parameters With Clinical Features Into a Predictive Model for Radiotherapy-Related Esophageal Fistula in Esophageal Squamous Cell Carcinoma
por: Li, Kaixin, et al.
Publicado: (2022)

Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery
por: Song, Congkuan, et al.
Publicado: (2022)

The clinical-histologic and prognostic characteristics in patients with a second primary non-small-cell lung cancer after a lobectomy
por: Wu, Lei-Lei, et al.
Publicado: (2023)

Risk of Second Primary Cancers Among Long-Term Survivors of Breast Cancer
por: Li, Dan, et al.
Publicado: (2020)

Clinicopathological characteristics of synchronous multiple primary early esophageal cancer and risk factors for multiple lesions
por: Su, Jing, et al.
Publicado: (2023)

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
por: Liu, Shan-peng, et al.
Publicado: (2022)

FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
por: Guo, Zixin, et al.
Publicado: (2021)

Modelled Economic Analysis for Dacomitinib–A Cost Effectiveness Analysis in Treating Patients With EGFR-Mutation-Positive Non-Small Cell Lung Cancer in China
por: Yu, Yong-feng, et al.
Publicado: (2021)

Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma
por: Wei, Meng Xia, et al.
Publicado: (2023)

Comparison of the Gross Target Volumes Based on Diagnostic PET/CT for Primary Esophageal Cancer
por: Shi, Jingzhen, et al.
Publicado: (2021)

Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer
por: Peng, Zi-Yang, et al.
Publicado: (2022)

Treatment- and immune-related adverse events of immune checkpoint inhibitors in esophageal or gastroesophageal junction cancer: A network meta-analysis of randomized controlled trials
por: Zheng, Jianqing, et al.
Publicado: (2022)

Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes
por: Yu, Yilin, et al.
Publicado: (2021)

Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer
por: Yao, Kui, et al.
Publicado: (2022)

Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer
por: Wu, Meijuan, et al.
Publicado: (2021)

Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis
por: Yu, Guanhua, et al.
Publicado: (2022)

Different functional lung-sparing strategies and radiotherapy techniques for patients with esophageal cancer
por: Zhou, Pi-Xiao, et al.
Publicado: (2022)

A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer
por: Wang, Guangchao, et al.
Publicado: (2020)

Tryptophan Metabolites as Biomarkers for Esophageal Cancer Susceptibility, Metastasis, and Prognosis
por: Chen, Yun, et al.
Publicado: (2022)

Lung Metastases in Newly Diagnosed Esophageal Cancer: A Population-Based Study
por: Guo, Jida, et al.
Publicado: (2021)

Progression Patterns, Treatment, and Prognosis Beyond Resistance of Responders to Immunotherapy in Advanced Non-Small Cell Lung Cancer
por: Xu, Yanjun, et al.
Publicado: (2021)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

The Key Clinical Questions of Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer—A Review
por: Han, Dan, et al.
Publicado: (2022)

The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer
por: Cheng, Chao, et al.
Publicado: (2022)

Airway Microbiota in Patients With Synchronous Multiple Primary Lung Cancer: The Bacterial Topography of the Respiratory Tract
por: Qian, Kai, et al.
Publicado: (2022)

Associations Between CAMKK1 Polymorphism rs7214723 and the Prognosis of Patients With Lung Cancer
por: Zhang, Haorui, et al.
Publicado: (2021)

EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer
por: Liu, Xiaojie, et al.
Publicado: (2021)

A Decision-Making Supporting Prediction Method for Breast Cancer Neoadjuvant Chemotherapy
por: Song, Dong, et al.
Publicado: (2021)

Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications
por: Zhou, Jianfeng, et al.
Publicado: (2021)

Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer
por: Xu, Yiyue, et al.
Publicado: (2021)

Effectiveness and Safety of Targeted Agents Combined With Chemoradiotherapy for the Treatment of Esophageal Cancer: A Network Meta-Analysis
por: Liu, Peng, et al.
Publicado: (2021)

Primary lung cancer in children and adolescents: Analysis of a surveillance, epidemiology, and end results database
por: Shao, Weipeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hcomlvo75ve54dmkbb3g1efvrs